The 10 that are cited most themselves, of 45.
Judgment of the Court (Fourth Chamber) of 24 November 2011. Medeva BV v Comptroller General of Patents, Designs and Trade Marks.Decision
Article 1 of Regulation No 469/2009, headed ‘Definitions’, provides as follows: ‘For the purposes of this Regulation, the following definitions shall apply: (a) “medicinal product” means any substance or combination of substances …
24 Nov 2011 · 62010CJ0322
Judgment of the Court (Fourth Chamber) of 24 November 2011. Georgetown University and Others v Comptroller General of Patents, Designs and TDecision
Article 1 of Regulation No 469/2009, headed ‘Definitions’, provides as follows: ‘For the purposes of this Regulation, the following definitions shall apply: “medicinal product” means any substance or combination of substances …
24 Nov 2011 · 62010CJ0422
Judgment of the Court (Eighth Chamber) of 15 January 2015. Arne Forsgren v Österreichisches Patentamt.Decision
По изложените съображения Съдът (осми състав) реши: 1) Член 1, буква б) и член 3, буква a) от Регламент (ЕО) № 469/2009 на Европейския …
15 Jan 2015 · 62013CJ0631
Judgment of the Court (Fourth Chamber), 19 July 2012. Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.Decision
Article 1 of the regulation provides: ‘Definitions For the purposes of this Regulation, the following definitions shall apply: “medicinal product” means any substance or combination of substances presented for treating or preventing …
19 Jul 2012 · 62011CJ0130
Order of the Court (Fourth Chamber) of 25 November 2011. University of Queensland and CSL Ltd v Comptroller General of Patents, Designs and Decision
Article 1 of Regulation No 469/2009, headed ‘Definitions’, provides as follows: ‘For the purposes of this Regulation, the following definitions shall apply: (a) “medicinal product” means any substance or combination of substances …
25 Nov 2011 · 62010CO0630
Order of the Court (Fourth Chamber) of 25 November 2011. Daiichi Sankyo Company v Comptroller General of Patents, Designs and Trade Marks.Decision
Article 1 of Regulation No 469/2009, headed ‘Definitions’, provides as follows: ‘For the purposes of this Regulation, the following definitions shall apply: “medicinal product” means any substance or combination of substances …
25 Nov 2011 · 62011CO0006
Judgment of the Court (Third Chamber), 12 December 2013. Actavis Group PTC EHF and Actavis UK Ltd v Sanofi.Decision
It is true that the Court has held, in a situation in which a ‘product’ within the meaning of Article 1 of Regulation No 469/2009 is protected by a number of basic patents in force, which may belong to different patent holders and may …
12 Dec 2013 · 62012CJ0443
Judgment of the Court (Third Chamber), 12 December 2013. Eli Lilly and Company Ltd v Human Genome Sciences Inc.Decision
Article 1 of Regulation No 469/2009, headed ‘Definitions’, provides as follows: ‘For the purposes of this Regulation, the following definitions shall apply: (a) “medicinal product” means any substance or combination of substances …
12 Dec 2013 · 62012CJ0493
Judgment of the Court (Grand Chamber) of 25 July 2018. Teva UK Ltd and Others v Gilead Sciences Inc.Decision
Article 1 of that regulation provides: ‘For the purposes of this Regulation, the following definitions shall apply: “medicinal product” means any substance or combination of substances presented for treating or preventing disease in …
25 Jul 2018 · 62017CJ0121
Order of the Court (Eighth Chamber), 14 November 2013. Glaxosmithkline Biologicals SA and Glaxosmithkline Biologicals, Niederlassung der SmiDecision
Article 1 of Regulation No 469/2009, headed ‘Definitions’, provides as follows: ‘For the purposes of this Regulation, the following definitions shall apply: “medicinal products” means any substance or combination of substances …
14 Nov 2013 · 62013CO0210